Crispr Therapeutics Ag (CRSP)

Other Income/Expenses (Net)

$83.76M

TTM · Period ending: · USD

CRSP logo

CRSP Other Income/Expenses (Net)

Latest reported$83.76M
CRSP Other Income/Expenses (Net) (-$236.00K → $83.76M)
High-resolution chart · PNG

CRSP other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-9,647,000
103,901,000
71,816,000
22,661,000
6,003,000
6,379,000
20,566,000
-5,485,000
-1,960,000
45,412,000
-92,000
-236,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.